Skip to content
37

painkiller

Skip it

Brand-locked demand (top 5 brands take 100% of clicks) — this niche doesn't clear our bar today.

Market size 24Growth 16Conversion 100Competition 3Returns 100Price range 43Avg price 50Brand share 0Review moat 76Quality gap 19

Conversion

Incredible27.5%

search→purchase rate — share of searches ending in a sale

Returns

Incredible0.0%

return rate — above 6% kills the launch gate

Review moat

Great474.83

avg incumbent reviews — the moat a new listing must climb

Avg price

Good€11.96

avg listing price — sweet spot $15–$100

Price range

Okay€6.59–€21.25

cheapest to priciest tracked listing — scored on the share inside $15–$100

Market size

Bad€98K

€98K/yr · 30K searches

Quality gap

Bad4.7★

avg incumbent rating — lower means beatable quality

Growth

Bad-18.9%

90-day search growth — must beat 0% to launch

Competition

Bad96%

top-5 click share — a locked-up shelf

Brand share

Bad100%

top-5 brand share — brand-locked demand

Competition

The top 5 products capture 96% of clicks — a locked-up shelf that new listings rarely crack.

Brands

4 falling

Sellers

22

Top-5 brand share

100%

Open market

0%

  • ratiopharm79%
  • Ibuhexal8%
  • vitenda7%
  • Faar Apo6%

Product shelf

Each bubble is one product — market share against review moat; bubble size tracks estimated sales, color grades how beatable the incumbent looks.

0%15%€15K30%€29K45%€44K60%€59K1101001K Reviews — right = deep review moat Market share (90d) ≈ est. sales
Beatable (≤4.3★) Contested Strong incumbent (>4.7★)

All 6 tracked products in this niche — three views at once, no toggling.

Demand & seasonality

Weekly Amazon search volume, last 104 weeks — -18.9% search growth over the last 90 days.
3K2KSpike '25Spike '26SepDecMarJunAugNovMarMay

Peak months: Jul, Aug, Sep · busiest ÷ quietest = 4.3×